GHRS Stock Analysis: Buy, Sell, or Hold?
$18.51
-0.74 (-3.84%)
▼
5d:
+0.38%
30d:
-0.27%
90d:
-37.23%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (63%)
Quality Score
40/100
Position
OVERSOLD
30-Day Fair Range
$18.52 – $20.80
Position: OVERSOLD
Forward P/E & Valuation
-10.4x
Next 12M consensus est.
Wall Street Target
$42.89
+122.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$17.96 / $21.40
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: GHRS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When GHRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GHRS is currently trading at $18.51, which is considered oversold relative to its 30-day fair value range of $18.52 to $20.80.
Technical Outlook: Technically, GHRS is in a strong downtrend. The price is currently testing key support at $17.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: GHRS scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.89 (+122.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GHRS is in a strong downtrend. The price is currently testing key support at $17.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: GHRS scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.89 (+122.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.52 -
$20.80
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
62.5%
Trading Range & Key Levels
30-Day Trading Range
$18.52 -
$20.80
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.80
(9.7%)
Support Level
$17.96
Resistance Level
$21.40
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 122.8% below Wall St target ($42.89)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-10.41
Wall Street Target
$42.89
(+122.8%)
Share GHRS Analysis
Share this live GHRS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GHRS)
Bearish
6 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
5 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits sentiment is bearish towards $GHRS, with concerns over the approval and market acceptance of ADASUVE, an inhalation medication developed by the company. No recent news articles were identified.
Key Retail Themes:
Market acceptance of ADASUVE
Clinical trial results
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:59 PM ET
Data refreshes hourly during market hours. Next update: 2:59 PM
Data refreshes hourly during market hours. Next update: 2:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GHRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
PVLA
Palvella Therapeutics, I… |
STRONG BUY
16 analysts |
$233 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GHRS Research Pages
